Table 3.
Comparison of coronavirus disease 2019 infection prevalence in different stages of chronic kidney disease
| Stages of CKD | No infection to COVID-19 (n=390), n (%) | Infection to COVID-19 (n=13), n (%) | P |
|---|---|---|---|
| CKD stage 1 A1 | 73 (18.7) | 4 (30.9) | 0.894 |
| CKD stage 1 A2 | 69 (17.7) | 1 (7.6) | |
| CKD stage 1 A3 | 7 (1.8) | 0 | |
| CKD stage 2 A1 | 72 (18.5) | 4 (30.9) | |
| CKD stage 2 A2 | 85 (21.8) | 0 | |
| CKD stage 2 A3 | 4 (1) | 1 (7.6) | |
| CKD stage 3a A1 | 47 (12.1) | 2 (15.4) | |
| CKD stage 3a A2 | 12 (3.1) | 1 (7.6) | |
| CKD stage 3a A3 | 1 (0.2) | 0 | |
| CKD stage 3b A1 | 6 (1.5) | 0 | |
| CKD stage 3b A2 | 7 (1.8) | 0 | |
| CKD stage 4 A1 | 1 (0.3) | 0 | |
| CKD stage 4 A3 | 6 (1.5) | 0 |
P<0.05 was considered statistically significant. CKD: Chronic kidney disease, COVID-19: Coronavirus disease 2019